View:
ctre-20210930
0001590717--12-312021Q3falsehttp://fasb.org/us-gaap/2021-01-31#HealthCareResidentServiceMemberhttp://fasb.org/us-gaap/2021-01-31#HealthCareResidentServiceMemberhttp://fasb.org/us-gaap/2021-01-31#HealthCareResidentServiceMemberhttp://fasb.org/us-gaap/2021-01-31#HealthCareResidentServiceMemberhttp://fasb.org/us-gaap/2021-01-31#HealthCareResidentServiceMemberhttp://fasb.org/us-gaap/2021-01-31#HealthCareResidentServiceMemberhttp://fasb.org/us-gaap/2021-01-31#HealthCareResidentServiceMemberhttp://fasb.org/us-gaap/2021-01-31#HealthCareResidentServiceMemberP5DP1Y00015907172021-01-012021-09-30xbrli:shares00015907172021-11-05iso4217:USD00015907172021-09-3000015907172020-12-31iso4217:USDxbrli:shares00015907172021-07-012021-09-3000015907172020-07-012020-09-3000015907172020-01-012020-09-300001590717us-gaap:CommonStockMember2020-12-310001590717us-gaap:AdditionalPaidInCapitalMember2020-12-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2020-12-310001590717us-gaap:CommonStockMember2021-01-012021-03-310001590717us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-3100015907172021-01-012021-03-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2021-01-012021-03-310001590717us-gaap:CommonStockMember2021-03-310001590717us-gaap:AdditionalPaidInCapitalMember2021-03-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2021-03-3100015907172021-03-310001590717us-gaap:CommonStockMember2021-04-012021-06-300001590717us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-3000015907172021-04-012021-06-300001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2021-04-012021-06-300001590717us-gaap:CommonStockMember2021-06-300001590717us-gaap:AdditionalPaidInCapitalMember2021-06-300001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2021-06-3000015907172021-06-300001590717us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2021-07-012021-09-300001590717us-gaap:CommonStockMember2021-09-300001590717us-gaap:AdditionalPaidInCapitalMember2021-09-300001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2021-09-300001590717us-gaap:CommonStockMember2019-12-310001590717us-gaap:AdditionalPaidInCapitalMember2019-12-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2019-12-3100015907172019-12-310001590717us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-3100015907172020-01-012020-03-310001590717us-gaap:CommonStockMember2020-01-012020-03-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2020-01-012020-03-310001590717us-gaap:CommonStockMember2020-03-310001590717us-gaap:AdditionalPaidInCapitalMember2020-03-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2020-03-3100015907172020-03-310001590717us-gaap:AdditionalPaidInCapitalMember2020-04-012020-06-3000015907172020-04-012020-06-300001590717us-gaap:CommonStockMember2020-04-012020-06-300001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2020-04-012020-06-300001590717us-gaap:CommonStockMember2020-06-300001590717us-gaap:AdditionalPaidInCapitalMember2020-06-300001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2020-06-3000015907172020-06-300001590717us-gaap:AdditionalPaidInCapitalMember2020-07-012020-09-300001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2020-07-012020-09-300001590717us-gaap:CommonStockMember2020-09-300001590717us-gaap:AdditionalPaidInCapitalMember2020-09-300001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2020-09-3000015907172020-09-30ctre:facility0001590717ctre:SkilledNursingMultiServiceCampusesAssistedLivingAndIndependentLivingFacilitiesMember2021-09-30ctre:bed0001590717ctre:SkilledNursingMultiServiceCampusesAssistedLivingAndIndependentLivingFacilitiesMember2021-01-012021-09-30ctre:statectre:property0001590717ctre:PropertiesWithPurchaseOptionLeaseExpirationOctober2034NextOption2022Memberctre:AssistedLivingFacilityMember2021-09-300001590717ctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2030NextOption2022Memberctre:SkilledNursingFacilityMember2021-09-300001590717ctre:PropertiesWithPurchaseOptionLeaseExpirationMarch2029NextOption2022Memberctre:SkilledNursingFacilityMember2021-09-300001590717ctre:SkilledNursingAndCampusFacilitiesMemberctre:PropertiesWithPurchaseOptionLeaseExpirationOctober2032NextOption2023Member2021-09-300001590717ctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2034NextOption2024Memberctre:SkilledNursingFacilityMember2021-09-300001590717ctre:PropertiesWithPurchaseOptionLeaseExpirationOctober2034NextOption2026Memberctre:AssistedLivingFacilityMember2021-09-300001590717ctre:SkilledNursingPropertiesMember2021-01-012021-09-30ctre:unit0001590717ctre:MultiServiceCampusPropertiesMember2021-01-012021-09-300001590717ctre:MultiServiceCampusPropertiesMembersrt:ScenarioForecastMember2022-01-012022-12-31ctre:lease0001590717ctre:NobleAmendedMasterLeasesMember2021-09-232021-09-23xbrli:pure0001590717ctre:NobleAmendedMasterLeasesMember2021-07-012021-09-300001590717ctre:NobleSeniorServicesAndNobleVAHoldingsLLCMemberctre:AssistedLivingFacilityMember2021-09-232021-09-230001590717ctre:NobleAmendedMasterLeasesMember2021-09-300001590717ctre:NobleSeniorServicesAndNobleVAHoldingsLLCMember2021-09-300001590717ctre:SkilledNursingFacilityMember2021-08-012021-08-010001590717ctre:EnsignMasterLeaseAmendedMember2021-08-01ctre:extension_option0001590717ctre:SkilledNursingFacilityMemberctre:EnsignMember2021-06-010001590717ctre:EnsignAmendedTripleNetMasterLeaseMember2021-06-010001590717ctre:EnsignAmendedTripleNetMasterLeaseMember2021-06-012021-06-010001590717ctre:AssistedLivingFacilityMemberctre:NobleVAHoldingsLLCMember2021-07-010001590717ctre:NobleVAAmendedMasterLeaseMember2021-07-010001590717ctre:NobleVAAmendedMasterLeaseMember2021-03-102021-03-100001590717ctre:NobleVAAmendedMasterLeaseMember2021-07-012021-07-010001590717ctre:AssistedLivingFacilityMemberctre:NobleVAHoldingsLLCMember2020-12-010001590717ctre:NobleTripleNetMasterLeaseMember2020-12-010001590717ctre:NobleTripleNetMasterLeaseMember2020-12-012020-12-010001590717us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2021-09-300001590717us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMemberctre:FiveOaksHealthcareLLCMember2020-12-310001590717us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberctre:FiveOaksHealthcareLLCMember2020-12-310001590717us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberctre:FiveOaksHealthcareLLCMember2021-02-012021-02-010001590717us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberctre:FiveOaksHealthcareLLCMember2021-02-010001590717us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberctre:FiveOaksHealthcareLLCMember2021-01-012021-03-310001590717us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberctre:MetronSkilledNursingFacilitiesMember2020-02-140001590717us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberctre:MetronSkilledNursingFacilitiesMember2020-02-142020-02-140001590717ctre:CascadeCapitalGroupLLCMemberus-gaap:MortgageReceivablesMember2020-02-140001590717us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberctre:MetronSkilledNursingFacilitiesMember2020-01-012020-03-310001590717ctre:CascadeCapitalGroupLLCMemberus-gaap:MortgageReceivablesMember2020-04-012020-04-300001590717ctre:CascadeCapitalGroupLLCMemberus-gaap:MortgageReceivablesMember2020-04-300001590717ctre:CascadeCapitalGroupLLCMemberus-gaap:MortgageReceivablesMember2020-07-012020-07-310001590717ctre:MezzanineLoanMemberctre:NextVAStarRealtyHoldingsLLCMember2020-11-300001590717srt:MinimumMemberctre:MezzanineLoanMemberctre:NextVAStarRealtyHoldingsLLCMember2020-11-300001590717srt:MaximumMemberctre:MezzanineLoanMemberctre:NextVAStarRealtyHoldingsLLCMember2020-11-300001590717ctre:MezzanineLoanMemberctre:NextVAStarRealtyHoldingsLLCMember2020-11-012020-11-300001590717ctre:MezzanineLoanMemberctre:NextVAStarRealtyHoldingsLLCMember2021-07-012021-09-300001590717ctre:MezzanineLoanMemberctre:NextVAStarRealtyHoldingsLLCMember2021-01-012021-09-300001590717ctre:MantecaValleyPostAcuteMemberus-gaap:MortgageReceivablesMember2019-07-012019-07-310001590717ctre:MantecaValleyPostAcuteMemberus-gaap:MortgageReceivablesMember2019-07-310001590717ctre:MantecaValleyPostAcuteMember2019-07-012019-07-310001590717ctre:CommuniCareMemberus-gaap:MortgageReceivablesMember2019-09-300001590717ctre:CascadeCapitalGroupLLCMemberus-gaap:MortgageReceivablesMember2020-02-290001590717us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberctre:MetronSkilledNursingFacilitiesMember2020-02-290001590717ctre:CascadeCapitalGroupLLCMember2020-04-300001590717us-gaap:LondonInterbankOfferedRateLIBORMemberctre:CascadeCapitalGroupLLCMemberus-gaap:MortgageReceivablesMember2020-04-300001590717us-gaap:MortgageReceivablesMember2021-09-300001590717us-gaap:MortgageReceivablesMember2021-07-012021-09-300001590717us-gaap:MortgageReceivablesMember2021-01-012021-09-300001590717us-gaap:MortgageReceivablesMember2020-07-012020-09-300001590717us-gaap:MortgageReceivablesMember2020-01-012020-09-300001590717us-gaap:LoansReceivableMember2021-07-012021-09-300001590717us-gaap:LoansReceivableMember2021-01-012021-09-300001590717us-gaap:LoansReceivableMember2020-07-012020-09-300001590717us-gaap:LoansReceivableMember2020-01-012020-09-300001590717ctre:PreferredEquityInvestmentCascadiaDevelopmentBoiseIDMember2016-09-300001590717us-gaap:PrimeRateMemberctre:PreferredEquityInvestmentCascadiaDevelopmentBoiseIDMember2016-09-012016-09-300001590717ctre:PreferredEquityInvestmentCascadiaDevelopmentBoiseIDMember2016-09-012016-09-300001590717ctre:SkilledNursingPropertiesMember2020-01-012020-01-310001590717ctre:PreferredEquityInvestmentCascadiaDevelopmentBoiseIDMember2020-01-012020-01-310001590717ctre:PreferredEquityInvestmentCascadiaDevelopmentBoiseIDMember2020-01-012020-09-300001590717us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberctre:MezzanineLoanMember2021-09-300001590717us-gaap:FairValueMeasurementsRecurringMemberctre:MezzanineLoanMemberus-gaap:FairValueInputsLevel2Member2021-09-300001590717us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberctre:MezzanineLoanMember2021-09-300001590717us-gaap:FairValueMeasurementsRecurringMemberctre:MezzanineLoanMember2021-09-300001590717us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberctre:MezzanineLoanMember2020-12-310001590717us-gaap:FairValueMeasurementsRecurringMemberctre:MezzanineLoanMemberus-gaap:FairValueInputsLevel2Member2020-12-310001590717us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberctre:MezzanineLoanMember2020-12-310001590717us-gaap:FairValueMeasurementsRecurringMemberctre:MezzanineLoanMember2020-12-310001590717us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember2021-09-300001590717us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember2020-12-310001590717ctre:ThreePointEightSevenFiveSeniorNotesDue2028Memberus-gaap:SeniorNotesMember2021-09-300001590717ctre:ThreePointEightSevenFiveSeniorNotesDue2028Memberus-gaap:SeniorNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2021-09-300001590717ctre:ThreePointEightSevenFiveSeniorNotesDue2028Memberus-gaap:SeniorNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2021-09-300001590717ctre:ThreePointEightSevenFiveSeniorNotesDue2028Memberus-gaap:SeniorNotesMember2020-12-310001590717ctre:ThreePointEightSevenFiveSeniorNotesDue2028Memberus-gaap:SeniorNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2020-12-310001590717ctre:ThreePointEightSevenFiveSeniorNotesDue2028Memberus-gaap:SeniorNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2020-12-310001590717us-gaap:SeniorNotesMemberctre:FivePointTwoFiveSeniorNotesDue2025Member2021-09-300001590717us-gaap:SeniorNotesMemberctre:FivePointTwoFiveSeniorNotesDue2025Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2021-09-300001590717us-gaap:SeniorNotesMemberctre:FivePointTwoFiveSeniorNotesDue2025Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2021-09-300001590717us-gaap:SeniorNotesMemberctre:FivePointTwoFiveSeniorNotesDue2025Member2020-12-310001590717us-gaap:SeniorNotesMemberctre:FivePointTwoFiveSeniorNotesDue2025Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2020-12-310001590717us-gaap:SeniorNotesMemberctre:FivePointTwoFiveSeniorNotesDue2025Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2020-12-310001590717ctre:SeniorUnsecuredTermLoanMemberus-gaap:LoansPayableMember2021-09-300001590717ctre:SeniorUnsecuredTermLoanMemberus-gaap:LoansPayableMember2020-12-310001590717us-gaap:RevolvingCreditFacilityMember2021-09-300001590717us-gaap:RevolvingCreditFacilityMember2020-12-310001590717us-gaap:SeniorNotesMemberctre:FivePointTwoFiveSeniorNotesDue2025Member2017-05-100001590717us-gaap:SeniorNotesMemberctre:FivePointTwoFiveSeniorNotesDue2025Member2017-05-102017-05-100001590717us-gaap:SeniorNotesMemberctre:FivePointTwoFiveSeniorNotesDue2025Member2021-07-012021-07-010001590717us-gaap:SeniorNotesMemberctre:FivePointTwoFiveSeniorNotesDue2025Member2021-07-012021-09-300001590717ctre:ThreePointEightSevenFiveSeniorNotesDue2028Memberus-gaap:SeniorNotesMember2021-06-170001590717ctre:ThreePointEightSevenFiveSeniorNotesDue2028Memberus-gaap:SeniorNotesMember2021-06-172021-06-170001590717ctre:ThreePointEightSevenFiveSeniorNotesDue2028Memberus-gaap:SeniorNotesMemberus-gaap:DebtInstrumentRedemptionPeriodTwoMember2021-06-172021-06-170001590717ctre:ThreePointEightSevenFiveSeniorNotesDue2028Memberus-gaap:DebtInstrumentRedemptionPeriodThreeMemberus-gaap:SeniorNotesMember2021-06-172021-06-170001590717ctre:ThreePointEightSevenFiveSeniorNotesDue2028Memberus-gaap:SeniorNotesMemberus-gaap:DebtInstrumentRedemptionPeriodOneMember2021-06-172021-06-170001590717us-gaap:RevolvingCreditFacilityMember2019-02-080001590717us-gaap:LetterOfCreditMember2019-02-080001590717ctre:SwinglineLoanMember2019-02-080001590717ctre:SeniorUnsecuredTermLoanMemberus-gaap:LoansPayableMember2019-02-080001590717srt:MinimumMemberus-gaap:BaseRateMemberus-gaap:RevolvingCreditFacilityMember2019-02-082019-02-080001590717us-gaap:BaseRateMembersrt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2019-02-082019-02-080001590717srt:MinimumMemberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:RevolvingCreditFacilityMember2019-02-082019-02-080001590717srt:MaximumMemberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:RevolvingCreditFacilityMember2019-02-082019-02-080001590717srt:MinimumMemberus-gaap:BaseRateMemberctre:SeniorUnsecuredTermLoanMemberus-gaap:LoansPayableMember2019-02-082019-02-080001590717us-gaap:BaseRateMemberctre:SeniorUnsecuredTermLoanMembersrt:MaximumMemberus-gaap:LoansPayableMember2019-02-082019-02-080001590717srt:MinimumMemberctre:SeniorUnsecuredTermLoanMemberus-gaap:LoansPayableMemberus-gaap:LondonInterbankOfferedRateLIBORMember2019-02-082019-02-080001590717ctre:SeniorUnsecuredTermLoanMembersrt:MaximumMemberus-gaap:LoansPayableMemberus-gaap:LondonInterbankOfferedRateLIBORMember2019-02-082019-02-080001590717srt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2019-02-082019-02-080001590717srt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2019-02-082019-02-080001590717us-gaap:RevolvingCreditFacilityMember2019-02-082019-02-080001590717srt:MaximumMemberctre:AtTheMarketOfferingProgramMember2020-03-100001590717ctre:AtTheMarketOfferingProgramMember2021-07-012021-09-300001590717ctre:AtTheMarketOfferingProgramMember2020-01-012020-09-300001590717ctre:AtTheMarketOfferingProgramMember2020-07-012020-09-300001590717ctre:AtTheMarketOfferingProgramMember2021-01-012021-09-300001590717ctre:AtTheMarketOfferingProgramMember2021-09-3000015907172020-03-200001590717us-gaap:RestrictedStockMemberctre:EnsignEmployeesMember2014-06-012014-06-010001590717us-gaap:RestrictedStockMemberctre:EnsignEmployeesMember2020-01-012020-12-310001590717us-gaap:RestrictedStockMemberctre:EnsignEmployeesMember2021-09-300001590717ctre:OfficerAndEmployeeMemberus-gaap:RestrictedStockMember2021-01-012021-01-310001590717ctre:OfficerAndEmployeeMemberus-gaap:RestrictedStockMember2021-02-012021-02-28ctre:installment0001590717ctre:OfficerAndEmployeeMemberus-gaap:RestrictedStockMember2021-01-310001590717ctre:OfficerAndEmployeeMemberus-gaap:RestrictedStockMember2021-02-280001590717us-gaap:PerformanceSharesMembersrt:OfficerMember2021-01-012021-01-310001590717us-gaap:PerformanceSharesMembersrt:MinimumMembersrt:OfficerMember2021-01-012021-01-310001590717us-gaap:PerformanceSharesMembersrt:MaximumMembersrt:OfficerMember2021-01-012021-01-310001590717us-gaap:PerformanceSharesMembersrt:OfficerMember2021-02-012021-02-28ctre:company0001590717us-gaap:PerformanceSharesMembersrt:MinimumMembersrt:OfficerMember2021-02-012021-02-280001590717us-gaap:PerformanceSharesMembersrt:MaximumMembersrt:OfficerMember2021-02-012021-02-280001590717us-gaap:PerformanceSharesMember2021-01-012021-02-280001590717us-gaap:RestrictedStockMembersrt:DirectorMember2021-04-012021-04-300001590717ctre:EnsignAndPennantMember2021-09-300001590717ctre:CapitalImprovementsAtTripleNetLeasedFacilitiesMember2021-09-300001590717ctre:SkilledNursingMultiServiceCampusesAssistedLivingAndIndependentLivingFacilitiesMemberctre:EnsignMember2021-09-30ctre:unit_bed0001590717ctre:EnsignMember2021-01-012021-09-300001590717us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberctre:EnsignMember2021-07-012021-09-300001590717us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberctre:EnsignMember2021-01-012021-09-300001590717us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberctre:EnsignMember2020-07-012020-09-300001590717us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberctre:EnsignMember2020-01-012020-09-300001590717ctre:PriorityManagementGroupLLCMemberctre:SkilledNursingAndCampusFacilitiesMember2021-09-300001590717us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberctre:PriorityManagementGroupLLCMember2021-01-012021-09-300001590717us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberctre:PriorityManagementGroupLLCMember2021-07-012021-09-300001590717us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberctre:PriorityManagementGroupLLCMember2020-01-012020-09-300001590717us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberctre:PriorityManagementGroupLLCMember2020-07-012020-09-30
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2021
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     

Commission File Number: 001-36181
CareTrust REIT, Inc.
(Exact name of registrant as specified in its charter)
Maryland46-3999490
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
905 Calle Amanecer, Suite 300, San Clemente, CA
92673
(Address of principal executive offices)(Zip Code)
(949) 542-3130
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareCTREThe Nasdaq Stock Market LLC
(Nasdaq Global Select Market)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.      Yes      No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).      Yes      No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).      Yes      No
As of November 5, 2021, there were 97,032,846 shares of common stock outstanding.





Table of Contents
INDEX
 
PART I—FINANCIAL INFORMATION
Item 1.
Item 2.
Item 3.
Item 4.
PART II—OTHER INFORMATION
Item 1.
Item 1A.
Item 2.
Item 6.





Table of Contents

PART I—FINANCIAL INFORMATION
Item 1. Financial Statements.

CARETRUST REIT, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)
(Unaudited)
 
September 30, 2021December 31, 2020
Assets:
Real estate investments, net$1,590,418 $1,448,099 
Other real estate investments15,150 15,000 
Assets held for sale, net4,891 7,226 
Cash and cash equivalents17,716 18,919 
Accounts and other receivables3,474 1,823 
Prepaid expenses and other assets, net10,710 10,450 
Deferred financing costs, net1,307 2,042 
Total assets$1,643,666 $1,503,559 
Liabilities and Equity:
Senior unsecured notes payable, net$394,063 $296,669 
Senior unsecured term loan, net199,084 198,925 
Unsecured revolving credit facility80,000 50,000 
Accounts payable, accrued liabilities and deferred rent liabilities26,740 19,572 
Dividends payable26,164 24,251 
Total liabilities726,051 589,417 
Commitments and contingencies (Note 10)
Equity:
Preferred stock, $0.01 par value; 100,000,000 shares authorized, no shares issued and outstanding as of September 30, 2021 and December 31, 2020
  
Common stock, $0.01 par value; 500,000,000 shares authorized, 96,296,673 and 95,215,797 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively
963 952 
Additional paid-in capital1,191,204 1,164,402 
Cumulative distributions in excess of earnings(274,552)(251,212)
Total equity917,615 914,142 
Total liabilities and equity$1,643,666 $1,503,559 










See accompanying notes to condensed consolidated financial statements.

1

Table of Contents
CARETRUST REIT, INC.
CONDENSED CONSOLIDATED INCOME STATEMENTS
(in thousands, except per share amounts)
(Unaudited)
 
 For the Three Months Ended September 30,For the Nine Months Ended September 30,
 2021202020212020
Revenues:
Rental income$48,087 $45,036 $141,077 $130,007 
Independent living facilities 634  1,874 
Interest and other income518 17 1,537 2,314 
Total revenues48,605 45,687 142,614 134,195 
Expenses:
Depreciation and amortization13,968 13,086 41,284 39,485 
Interest expense5,692 5,519 17,988 18,082 
Property taxes1,004 857 2,466 2,179 
Independent living facilities  568  1,660 
General and administrative5,196 4,105 16,136 12,921 
Total expenses25,860 24,135 77,874 74,327 
Other loss:
Loss on extinguishment of debt(10,827) (10,827) 
Loss on sale of real estate  (192)(56)
Total other losses(10,827) (11,019)(56)
Net income$11,918 $21,552 $53,721 $59,812 
Earnings per common share:
Basic$0.12 $0.23 $0.56 $0.63 
Diluted$0.12 $0.23 $0.56 $0.63 
Weighted-average number of common shares:
Basic96,297 95,214 95,922 95,195 
Diluted96,297 95,214 95,937 95,195 












See accompanying notes to condensed consolidated financial statements.
2

Table of Contents
CARETRUST REIT, INC.
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
(in thousands, except share and per share amounts)
(Unaudited)


Common StockAdditional
Paid-in
Capital
Cumulative
Distributions in Excess of Earnings
Total
Equity
SharesAmount
Balance at January 1, 202195,215,797 $952 $1,164,402 $(251,212)$914,142 
Issuance of common stock, net702,000 7 16,184 — 16,191 
Vesting of restricted common stock, net of shares withheld for employee taxes63,265 1 (1,331)— (1,330)
Amortization of stock-based compensation— — 1,585 — 1,585 
Common dividends ($0.265 per share)
— — — (25,633)(25,633)
Net income— — — 20,486 20,486 
Balance at March 31, 202195,981,062 $960 $1,180,840 $(256,359)$925,441 
Issuance of common stock, net288,000 3 6,752 — 6,755 
Vesting of restricted common stock27,611 — — — — 
Amortization of stock-based compensation— — 1,810 — 1,810 
Common dividends ($0.265 per share)
— — — (25,714)(25,714)
Net income— — — 21,317 21,317 
Balance at June 30, 202196,296,673 $963 $1,189,402 $(260,756)$929,609 
Amortization of stock-based compensation— — 1,802 — 1,802 
Common dividends ($0.265 per share)
— — — (25,714)(25,714)
Net income— — — 11,918 11,918 
Balance at September 30, 202196,296,673 $963 $1,191,204 $(274,552)$917,615 



























See accompanying notes to condensed consolidated financial statements.

3

Table of Contents
CARETRUST REIT, INC.
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
(in thousands, except share and per share amounts)
(Unaudited)
 Common StockAdditional
Paid-in
Capital
Cumulative
Distributions in Excess of Earnings
Total
Equity
SharesAmount
Balance at January 1, 202095,103,270 $951 $1,162,990 $(236,350)$927,591 
Issuance of common stock, net— — (90)— (90)
Vesting of restricted common stock, net of shares withheld for employee taxes93,061 1 (1,987)— (1,986)
Amortization of stock-based compensation— — 884 — 884 
Common dividends ($0.25 per share)
— — — (23,931)(23,931)
Net income— — — 19,325 19,325 
Balance at March 31, 202095,196,331 $952 $1,161,797 $(240,956)$921,793 
Issuance of common stock, net— — (314)— (314)
Vesting of restricted common stock17,749 — — — — 
Amortization of stock-based compensation— — 963 — 963 
Common dividends ($0.25 per share)
— — — (23,931)(23,931)
Net income— — — 18,935 18,935 
Balance at June 30, 202095,214,080 $952 $1,162,446 $(245,952)$917,446 
Amortization of stock-based compensation— — 972 — 972 
Common dividends ($0.25 per share)
— — — (23,934)(23,934)
Net income— — — 21,552 21,552 
Balance at September 30, 202095,214,080 $952 $1,163,418 $(248,334)$916,036 















See accompanying notes to condensed consolidated financial statements.
4

Table of Contents
CARETRUST REIT, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)
 For the Nine Months Ended September 30,
 20212020
Cash flows from operating activities:
Net income$53,721 $59,812 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization (including below-market ground leases)41,328 39,529 
Amortization of deferred financing costs1,531 1,462 
Loss on extinguishment of debt10,827  
Amortization of stock-based compensation5,197 2,819 
Straight-line rental income(26)(65)
Loss on sale of real estate192 56 
Interest income distribution from other real estate investment 1,346 
Change in operating assets and liabilities:
Accounts and other receivables(1,775)543 
Prepaid expenses and other assets, net(20)267 
Accounts payable, accrued liabilities and deferred rent liabilities7,388 2,616 
Net cash provided by operating activities118,363 108,385 
Cash flows from investing activities:
Acquisitions of real estate, net of deposits applied(180,323)(42,075)
Purchases of equipment, furniture and fixtures and improvements to real estate(4,826)(6,294)
Investment in real estate mortgage and other loans receivable(700)(13,958)
Principal payments received on real estate mortgage and other loans receivable 172 80,873 
Repayment of other real estate investment 2,327 
Escrow deposits for potential acquisitions of real estate(3,100)(1,000)
Net proceeds from sales of real estate6,814 2,189 
Net cash (used in) provided by investing activities(181,963)22,062 
Cash flows from financing activities:
Proceeds from (costs paid for) the issuance of common stock, net22,946 (404)
Proceeds from the issuance of senior unsecured notes payable400,000  
Borrowings under unsecured revolving credit facility220,000 15,000 
Payments on senior unsecured notes payable(300,000) 
Payments on unsecured revolving credit facility(190,000)(75,000)
Payments on debt extinguishment and deferred financing costs(14,070) 
Net-settle adjustment on restricted stock(1,331)(1,986)
Dividends paid on common stock(75,148)(69,283)
Net cash provided by (used in) financing activities62,397 (131,673)
Net decrease in cash and cash equivalents(1,203)(1,226)
Cash and cash equivalents as of the beginning of period18,919 20,327 
Cash and cash equivalents as of the end of period$17,716 $19,101 
Supplemental disclosures of cash flow information:
Interest paid$13,267 $12,671 
Supplemental schedule of noncash investing and financing activities:
Increase in dividends payable$1,913 $2,513 
Right-of-use asset obtained in exchange for new operating lease obligation$ $599 
Transfer of pre-acquisition costs to acquired assets$358 $167 
Sale of real estate settled with notes receivable$ $32,400 
See accompanying notes to condensed consolidated financial statements.
5

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)



1. ORGANIZATION
Description of Business—CareTrust REIT, Inc.’s (“CareTrust REIT” or the “Company”) primary business consists of acquiring, financing, developing and owning real property to be leased to third-party tenants in the healthcare sector. As of September 30, 2021, the Company owned and leased to independent operators, 225 skilled nursing, multi-service campuses, assisted living and independent living facilities consisting of 23,541 operational beds and units located in 28 states with the highest concentration of properties by rental revenues located in California, Texas, Louisiana, Idaho and Arizona. As of September 30, 2021, the Company also had other real estate investments consisting of one mezzanine loan receivable with a carrying value of $15.2 million.
COVID-19—The COVID-19 pandemic led governments and other authorities around the world, including federal, state and local authorities in the United States, to impose measures intended to reduce its spread, including restrictions on freedom of movement and business operations such as travel bans, border closings, business limitations and closures (subject to exceptions for essential operations and businesses), quarantines and shelter-in-place orders. Although most of these governmental restrictions have since been lifted or scaled back, resurgences of COVID-19 and the emergence of new variants thereof have resulted in the reimposition of certain restrictions and requirements, including restrictions imposed on unvaccinated individuals and employee vaccine mandates, and may lead to other restrictions and requirements being reimplemented in response to efforts to reduce the spread of COVID-19. Given the dynamic nature of these circumstances and the related adverse impact these restrictions have had, and may continue to have, on the economy generally, the Company’s business, results of operations and financial condition may be adversely impacted by the COVID-19 pandemic.
The duration and extent of the COVID-19 pandemic’s effect on the Company’s operational and financial performance, and the operational and financial performance of the Company’s tenants, will depend on future developments, which are highly uncertain and cannot be predicted at this time, including the rate of public acceptance and usage of vaccines and the effectiveness of vaccines in limiting the spread of COVID-19 and its variants, resurgences of COVID-19 and, in particular, new and more contagious and/or vaccine resistant variants, actions taken to contain the spread of COVID-19 and how quickly and to what extent normal economic and operating conditions can resume. The adverse impact of the COVID-19 pandemic on the Company’s business, results of operations and financial condition could be material.
 
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation—The accompanying condensed consolidated financial statements of the Company were prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and Article 10 of Regulation S-X. Accordingly, the condensed consolidated financial statements do not include all of the disclosures required by GAAP for a complete set of annual audited financial statements. The condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020. In the opinion of management, all adjustments which are of a normal and recurring nature and considered necessary for a fair presentation of the results of the interim periods presented have been included. The results of operations for the interim periods are not necessarily indicative of results for the full year. All intercompany transactions and account balances within the Company have been eliminated.
 Recent Accounting Pronouncements—In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”), that provides optional relief to applying reference rate reform to contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”). For U.S. Dollar LIBOR, the overnight, one-month, three-month, six-month and one-year LIBOR rates will be discontinued in June 2023, while other U.S. Dollar LIBOR rates will be discontinued at the end of 2021. The amendments in this update are effective immediately and may be applied through December 31, 2022. The Company is still evaluating the impact of ASU 2020-04 and expects to take full advantage of the offered optional expedients and exceptions, but does not expect the adoption of the standard to have a material impact on the Company’s consolidated financial statements.

6

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


3. REAL ESTATE INVESTMENTS, NET
The following table summarizes the Company’s investment in owned properties as of September 30, 2021 and December 31, 2020 (dollars in thousands):
September 30, 2021December 31, 2020
Land$251,347 $205,356 
Buildings and improvements1,609,834 1,477,849 
Integral equipment, furniture and fixtures103,739 97,836 
Identified intangible assets1,257 2,352 
Real estate investments1,966,177 1,783,393 
Accumulated depreciation and amortization(375,759)(335,294)
Real estate investments, net$1,590,418 $1,448,099 
As of September 30, 2021, all 225 of the Company’s facilities were leased to various operators under triple-net leases. All of these leases contain annual escalators based on the percentage change in the Consumer Price Index (“CPI”) (but not less than zero), some of which are subject to a cap, or fixed rent escalators.
As of September 30, 2021, the Company’s total future contractual minimum rental income for all of its tenants, excluding operating expense reimbursements, was (dollars in thousands):
YearAmount
2021 (three months)$47,765 
2022191,229 
2023191,024 
2024189,679 
2025189,650 
2026189,755 
Thereafter1,128,717 
Total$2,127,819 
Tenant Purchase Options
Certain of the Company’s operators hold purchase options allowing them to acquire properties they currently lease from the Company. A summary of these purchase options is presented below (dollars in thousands):
Asset TypePropertiesLease ExpirationNext Option Open Date
Option Type(1)
Current Cash Rent(2)
ALF7October 20341/1/2022A$3,282 
SNF11November 20301/1/2022C4,944 
SNF1March 20294/1/2022
B / C(3)
779 
SNF / Campus2October 20321/1/2023B998 
SNF4November 203412/1/2024B3,789 
ALF2October 20341/1/2026A1,565 
(1) Option type includes:
A - Fixed base price plus a specified share on any appreciation.
B - Fixed base price.
C - Fixed capitalization rate on lease revenue.
(2) Based on annualized cash revenue for contracts in place as of September 30, 2021.
(3) Purchase option reflects two option types.
7

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


Rental Income
The following table summarizes components of the Company’s rental income (dollars in thousands):
For the Three Months Ended September 30,
For the Nine Months Ended September 30,
Rental Income2021202020212020
Contractual rent due(1)
$48,081 $42,866 $140,988 $127,789 
Straight-line rent6 17 26 65 
Recovery of previously reversed rent(2)
 1,047  1,047 
Lease termination revenue(2)
 1,106 63 1,106 
Total$48,087 $45,036 $141,077 $130,007 
(1) Includes initial cash rent and tenant operating expense reimbursements, as adjusted for applicable rental escalators and rent increases due to capital expenditures funded by the Company. For tenants on a cash basis, this represents the lesser of the amount that would be recognized on a straight-line basis or cash that has been received.
(2) During the three and nine months ended September 30, 2020, the Company recovered approximately $1.0 million in rental revenue related to affiliates of Metron Integrated Health Systems (“Metron”) that was previously written off. In addition, in connection with the agreement to terminate its lease agreements with Metron and to sell the facilities to a third party, the Company received certain lease termination payments from Metron. During the nine months ended September 30, 2021, the Company recognized approximately $0.1 million in lease termination revenue. During the three and nine months ended September 30, 2020, the Company received approximately $1.1 million in lease termination revenue.
Recent Real Estate Acquisitions
The following table summarizes the Company’s acquisitions for the nine months ended September 30, 2021 (dollars in thousands):
Type of Property
Purchase Price(1)
Initial Annual Cash RentNumber of Properties
Number of Beds/Units(2)
Skilled nursing$57,973 $4,499 (3)4 509 
Multi-service campuses125,708 8,604 (4)4 640 
Total$183,681 $13,103 8 1,149 
(1) Purchase price includes capitalized acquisition costs.
(2) The number of beds/units includes operating beds at the acquisition date.
(3) Initial annual cash rent represents initial cash rent for the first twelve months excluding any impact of straight-line rent.
(4) Initial annual cash rent represents the first twelve months of rent upon commencement of the Company’s long-term net leases, which occurred during the three months ended June 30, 2021, upon the tenants’ receipt of licensing approval and increases to $9.4 million in the second year with CPI-based annual escalators thereafter.

8

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


Lease Amendments
Amended Noble Master Leases. During the three months ended September 30, 2021, the Company did not collect a portion of rent from affiliates of Noble Senior Services and Noble VA Holdings, LLC (collectively, “Noble”). On September 23, 2021, the Company amended its two existing triple-net master leases with Noble. The lease amendment granted a deferral for a total of $1.8 million of unpaid base rent, which represented approximately 4% of the Company’s total contractual base rent for the three months ended September 30, 2021. In connection with its agreement to the rent deferral, the Company also entered into a purchase agreement with Noble to acquire two assisted living facilities owned by Noble, which will be leased back to Noble under a short-term lease agreement upon closing of the acquisition while the Company pursues other tenants for the long-term. The lease amendment requires the deferred rent, as well as all contractual rent for the fourth quarter of 2021, to be paid in full upon closing the purchase of the two facilities. If the closing under the purchase agreement is not consummated within the timeframe provided in the purchase agreement, all unpaid rent will become immediately due and payable under the terms of the applicable master lease agreements. During the three months ended September 30, 2021, the Company recognized $2.2 million of rental income, exclusive of operating expense reimbursements, related to Noble’s master leases and recorded a corresponding rent receivable of $1.8 million, included within accounts and other receivables on the Company’s condensed consolidated balance sheets. As of September 30, 2021, the Company had $1.1 million of cash security deposits on-hand related to Noble.
Amended Ensign Master Lease. On August 1, 2021, the Company acquired two skilled nursing facilities. The facilities were leased to affiliates of The Ensign Group, Inc. (“Ensign”). In conjunction with the acquisition of the two facilities, the Company amended and extended the initial term of an existing triple-net master lease with Ensign to include the two skilled nursing facilities. The Ensign lease, as amended, has a remaining initial term of approximately 17 years, with three five-year renewal options and CPI-based rent escalators. Annual cash rent under the amended lease increased by approximately $2.2 million, with GAAP rent increasing by $2.5 million due to a $5.0 million prepayment of rent made at closing, which is being amortized on a straight-line basis over the remaining lease term.
Five Oaks Lease Termination and Amended Ensign Master Lease. On June 1, 2021, operating affiliates of Ensign acquired certain operations and assets of Five Oaks Healthcare, LLC (“Five Oaks”) under an agreement with Five Oaks. The agreement granted Ensign the right to occupy and operate four of the Company’s skilled nursing facilities in Washington that were previously being operated by Five Oaks. In conjunction with consenting to the transfer, the Company terminated the existing Five Oaks master lease, and amended and extended the term of an existing triple-net master lease with Ensign to include the four skilled nursing facilities. The Ensign lease, as amended, has a remaining term of approximately 15 years, with three five-year renewal options and CPI-based rent escalators. Annual cash rent under the terminated Five Oaks master lease was approximately $2.6 million, and annual cash rent under the amended Ensign lease increased by the same amount.
Premier Partial Lease Termination and Amended Noble VA Master Lease. On March 10, 2021 and July 1, 2021, two assisted living facilities in Wisconsin operated by affiliates of Premier Senior Living, LLC (“Premier”) were transferred to affiliates of Noble VA Holdings, LLC (“Noble VA”). In connection with the transfer, the Company partially terminated the Premier master lease and amended the existing triple-net master lease with Noble VA to include the two assisted living facilities. The Noble VA master lease, as amended, has a remaining term of approximately 13 years, with two five-year renewal options and CPI-based rent escalators. Initial annual cash rent under the amended Noble VA master lease increased by approximately $1.3 million on March 10, 2021 and approximately $1.0 million on July 1, 2021 and annual cash rent under the partially terminated Premier master lease decreased by approximately the same amount. See above under “Amended Noble Master Leases” for additional information regarding the Company’s leases with Noble.
Twenty/20 Lease Termination and New Noble VA Master Lease. On December 1, 2020, five assisted living facilities in Virginia operated by Twenty/20 Management, Inc. (“Twenty/20”) were transferred to affiliates of Noble VA. In connection with the transfer, the Company entered into a new triple-net master lease with Noble VA. The new lease has a remaining initial term of approximately 14 years, with two five-year renewal options and CPI-based rent escalators. Initial annual cash rent under the new lease is approximately $3.2 million. See above under “Amended Noble Master Leases” for additional information regarding the Company’s leases with Noble.
Assets Held for Sale and Asset Sales
During the third quarter of 2021, the Company met the held for sale criteria on one assisted living facility operated by affiliates of Noble. As of September 30, 2021, the property continued to be held for sale and the carrying value of $4.9 million was primarily comprised of real estate assets.
9

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


During the fourth quarter of 2020, the Company met the criteria to classify one skilled nursing facility operated by affiliates of Five Oaks as held for sale. On February 1, 2021, the Company closed on the sale of the one skilled nursing facility consisting of 90 beds located in Washington with a carrying value of $7.2 million, for net sales proceeds of $7.0 million. During the three months ended March 31, 2021, the Company recorded a loss of $0.2 million in connection with the sale.
On February 14, 2020, the Company closed on the sale of six skilled nursing facilities formerly operated by affiliates of Metron. In connection with the sale for $36.0 million, the Company received $3.5 million in cash and provided subsidiaries of Cascade Capital Group, LLC (“Cascade”), the purchaser of the properties, with a short-term mortgage loan secured by these properties for $32.4 million. The mortgage loan bore interest at 7.5% and initially had a maturity date of March 31, 2020. In connection with the sale, the Company recognized a loss of approximately $0.1 million during the three months ended March 31, 2020. In April 2020, the mortgage loan was settled with $18.9 million in cash and a new mortgage loan for $13.9 million. In July 2020, the Company received prepayment in full, including accrued interest, for the new $13.9 million mortgage loan. See Note 4, Other Real Estate Investments, Net, for further detail on the mortgage loan.

4. OTHER REAL ESTATE INVESTMENTS, NET
Mezzanine Loan Receivable—In November 2020, the Company provided Next VA Star Realty Holdings, LLC a mezzanine loan for nine skilled nursing facilities secured by membership interests in affiliates of Next VA Star Realty Holdings, LLC for approximately $15.0 million, at an annual interest rate of 12%. The loan requires monthly interest payments, is set to mature on November 30, 2025, and may (subject to certain restrictions) be prepaid before the maturity date if paid in full and for an exit fee ranging from 1% to 3% of the loan plus unpaid interest payments equal to 24 months (less the amount of monthly interest payments made by the borrower through the date of prepayment). During the three and nine months ended September 30, 2021, the Company recognized $0.5 million and $1.4 million, respectively, of interest income related to its mezzanine loan.
Mortgage Loans Receivable—In July 2019, the Company provided MCRC, LLC a real estate loan secured by a 176-bed skilled nursing facility in Manteca, California for $3.0 million, which bore a fixed interest rate of 8% and required monthly interest payments. Concurrently, the Company entered into a purchase and sale agreement to purchase the Manteca facility from MCRC, LLC for approximately $16.4 million subject to normal diligence and other contingencies. The loan documents provided for a maturity date of the earlier to occur of the closing date of the acquisition, or five business days following the termination of the purchase and sale agreement.  MCRC, LLC breached its obligation to sell the Manteca facility to the Company on the terms outlined in the purchase and sale agreement and to repay the real estate loan upon its stated maturity. As a result, the Company commenced non-judicial foreclosure proceedings with respect to the Manteca facility. In January 2020, the borrower further collateralized the loan by causing one of its affiliates to grant the Company a deed of trust in the real estate and improvements that constitute Palm Gardens Assisted Living Facility in Yolo County, California. During the three months ended June 30, 2020, payment for the loan principal and accrued interest, including default interest, as well as reimbursement for attorney’s fees and certain other costs of suit, were received in full by the Company and, as a result, the Company withdrew all foreclosure-related proceedings related to the Manteca facility loan.
In September 2019, the Company provided affiliates of CommuniCare Family of Companies (“CommuniCare”) a $26.5 million loan secured by mortgages on the three skilled nursing facilities sold to CommuniCare, which bore a fixed interest rate of 10%. The mortgage loan, which required CommuniCare to make monthly interest payments, was set to mature on February 29, 2020 and included an option to be prepaid before the maturity date. In January 2020, the Company amended the mortgage loan’s maturity date to April 30, 2020. In April 2020, the Company amended the mortgage loan’s maturity date to May 29, 2020. During the three months ended June 30, 2020, payment for the mortgage loan and accrued interest was received in full by the Company.
In February 2020, the Company provided subsidiaries of Cascade a $32.4 million loan secured by mortgages on the six skilled nursing facilities formerly operated by affiliates of Metron and sold to Cascade in February 2020, as discussed in Note 3, Real Estate Investments, Net. The mortgage loan bore interest at 7.5% and initially had a maturity date of March 31, 2020. In April 2020, the mortgage loan was settled in connection with a new mortgage loan transaction between the Company and a third-party institutional lender as co-lenders, pursuant to which the Company received $18.9 million in cash and issued a new mortgage loan for $13.9 million. The new mortgage loan with Cascade was secured by the same six skilled nursing facilities purchased by Cascade and was for a combined principal amount of $33.9 million, with the Company’s $13.9 million portion of the indebtedness initially bearing interest at a variable rate equal to LIBOR plus 4.00%, subject to a LIBOR floor of 1.75%. The new mortgage loan had a maturity date of April 29, 2022 and included two six-month extension options. In July 2020, prepayment for the mortgage loan of $13.9 million and accrued interest was received in full by the Company.
As of September 30, 2021, the Company had no mortgage loan receivables.
10

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


During both the three and nine months ended September 30, 2021, the Company recognized no interest income related to mortgage loans. During the three and nine months ended September 30, 2020, the Company recognized zero and $2.0 million of interest income, respectively, related to its mortgage loans. During the three and nine months ended September 30, 2021, the Company recognized $0.1 million and $0.2 million of interest income, respectively, related to its other loans receivable. During the three and nine months ended September 30, 2020, the Company recognized $17,000 and $0.2 million of interest income, respectively, related to its other loans receivable.
Preferred Equity Investments—In September 2016, the Company completed a $2.3 million preferred equity investment with an affiliate of Cascadia Development, LLC. The preferred equity investment yielded a return equal to prime plus 9.5% but in no event less than 12.0% calculated on a quarterly basis on the outstanding carrying value of the investment. The investment was used to develop a 99-bed skilled nursing facility in Boise, Idaho. In connection with its investment, the Company obtained an option to purchase the development at a fixed-formula price upon stabilization, with an initial lease yield of at least 9.0%. The project was completed in the first quarter of 2018 and began lease-up during the second quarter of 2018. In January 2020, the Company purchased the skilled nursing facility for approximately $18.7 million, inclusive of transaction costs. The Company paid $15.0 million after receiving back its initial investment of $2.3 million and cumulative contractual preferred return through January 17, 2020, the acquisition date, of $1.4 million, of which less than $0.1 million was recognized as interest income during the nine months ended September 30, 2020. The Company did not recognize any interest income during the three months ended September 30, 2020 or the three and nine months ended September 30, 2021 related to preferred equity investments. As of September 30, 2021, the Company had no preferred equity investments.
5. FAIR VALUE MEASUREMENTS
The Company determines fair value based on quoted prices when available or through the use of alternative approaches, such as discounting the expected cash flows using market interest rates commensurate with the credit quality and duration of the investment. GAAP guidance defines three levels of inputs that may be used to measure fair value:

Level 1 – Quoted prices in active markets for identical assets and liabilities that the reporting entity has the ability to access at the measurement date.

Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability or can be corroborated with observable market data for substantially the entire contractual term of the asset or liability.

Level 3 – Unobservable inputs reflect the entity’s own assumptions about the assumptions that market participants would use in the pricing of the asset or liability and are consequently not based on market activity, but rather through particular valuation techniques.

The determination of where an asset or liability falls in the hierarchy requires significant judgment and considers factors specific to the asset or liability. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company evaluates its hierarchy disclosures each quarter and, depending on various factors, it is possible that an asset or liability may be classified differently from quarter to quarter. Changes in the type of inputs may result in a reclassification for certain assets. The Company does not expect that changes in classifications between levels will be frequent.
Items Measured at Fair Value on a Recurring Basis
The following table presents information about the Company’s assets and liabilities measured at fair value on a recurring basis as of September 30, 2021 and December 31, 2020, aggregated by the level in the fair value hierarchy within which those instruments fall (dollars in thousands):
Level 1Level 2Level 3
Balance as of September 30, 2021
Assets:
Mezzanine loan receivable$ $ $15,150 $15,150 
Level 1Level 2Level 3
Balance as of December 31, 2020
Assets:
Mezzanine loan receivable$ $ $15,000 $15,000 

11

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


Mezzanine loan receivable: The fair value of the mezzanine loan receivable was estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value, market interest rates and other credit enhancements. As such, the Company classifies the instrument as Level 3 due to the significant unobservable inputs used in determining market interest rates for investments with similar terms. Future changes in market interest rates could materially impact the estimated discounted cash flows. As of September 30, 2021 and December 31, 2020, the Company did not have any loans that were 90 days or more past due.
For the three and nine months ended September 30, 2021, there were no classification changes in assets and liabilities with Level 3 inputs in the fair value hierarchy.

Items Disclosed at Fair Value

Considerable judgment is necessary to estimate the fair value disclosure of financial instruments. The estimates of fair value presented herein are not necessarily indicative of the amounts that could be realized upon disposition of the financial instruments. A summary of the face values, carrying amounts and fair values of the Company’s financial instruments as of September 30, 2021 and December 31, 2020 using Level 2 inputs for the Notes and the 2025 Notes (each as defined in Note 6, Debt, below), is as follows (dollars in thousands):  
 September 30, 2021December 31, 2020
 LevelFace
Value
Carrying
Amount
Fair
Value
Face
Value
Carrying
Amount
Fair
Value
Financial liabilities:
2028 Senior unsecured notes payable2$400,000 $394,063 $415,000 $ $ $ 
2025 Senior unsecured notes payable2   300,000 296,669 311,430 

Cash and cash equivalents, accounts and other receivables, other loans receivable, accounts payable, and accrued liabilities: These balances approximate their fair values due to the short-term nature of these instruments.

Unsecured revolving credit facility and senior unsecured term loan: The fair values approximate their carrying values as the interest rates are variable and approximate prevailing market interest rates for similar debt arrangements.

6. DEBT
The following table summarizes the balance of the Company’s indebtedness as of September 30, 2021 and December 31, 2020 (dollars in thousands):
September 30, 2021December 31, 2020
Principal AmountDeferred Loan FeesCarrying ValuePrincipal AmountDeferred Loan FeesCarrying Value
2028 Senior unsecured notes payable$400,000 $(5,937)$394,063 $ $ $ 
2025 Senior unsecured notes payable   300,000 (3,331)296,669 
Senior unsecured term loan200,000 (916)199,084 200,000 (1,075)198,925 
Unsecured revolving credit facility80,000  80,000 50,000  50,000 
$680,000 $(6,853)$673,147 $550,000 $(4,406)$545,594 

Senior Unsecured Notes Payable
2025 Senior Notes. On May 10, 2017, the Company’s wholly owned subsidiary, CTR Partnership, L.P. (the “Operating Partnership”), and its wholly owned subsidiary, CareTrust Capital Corp. (together with the Operating Partnership, the “Issuers”), completed an underwritten public offering of $300.0 million aggregate principal amount of 5.25% Senior Notes due 2025 (the “2025 Notes”). The 2025 Notes were issued at par, resulting in gross proceeds of $300.0 million and net proceeds of approximately $294.0 million after deducting underwriting fees and other offering expenses. The 2025 Notes were scheduled to mature on June 1, 2025 and bore interest at a rate of 5.25% per year. Interest on the 2025 Notes was payable on June 1 and December 1 of each year. On July 1, 2021 (the “Redemption Date”), the Issuers redeemed all $300.0 million aggregate principal amount of the 2025 Notes at a redemption price equal to 102.625% of the principal amount of the 2025 Notes, plus
12

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


accrued and unpaid interest thereon up to, but not including, the Redemption Date. During the third quarter of 2021, the Company recorded a loss on extinguishment of debt of $10.8 million in the condensed consolidated income statements, including a prepayment penalty of $7.9 million and a $2.9 million write-off of deferred financing costs associated with the redemption of the 2025 Notes.
2028 Senior Notes. On June 17, 2021, the Issuers completed a private offering of $400.0 million aggregate principal amount of 3.875% Senior Notes due 2028 (the “Notes”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A and to non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act of 1933, as amended. The Notes were issued at par, resulting in gross proceeds of $400.0 million and net proceeds of approximately $393.8 million after deducting underwriting fees and other offering expenses. The Notes mature on June 30, 2028. The Notes accrue interest at a rate of 3.875% per annum payable semiannually in arrears on June 30 and December 30 of each year, commencing on December 30, 2021.
The Issuers may redeem some or all of the Notes at any time prior to March 30, 2028 at a price equal to 100% of the principal amount of the Notes redeemed plus accrued and unpaid interest on the Notes, if any, to, but not including, the redemption date, plus a “make-whole” premium. At any time on or after March 30, 2028, the Issuers may redeem some or all of the Notes at a redemption price equal to 100% of the principal amount of the Notes redeemed plus accrued interest on the Notes, if any, to, but not including, the redemption date. In addition, at any time on or prior to June 30, 2024, up to 40% of the aggregate principal amount of the Notes may be redeemed with the net proceeds of certain equity offerings at a redemption price of 103.875% of the aggregate principal amount of Notes to be redeemed plus accrued and unpaid interest on the Notes, if any, to, but not including, the redemption date. If certain changes of control of the Company occur, the Issuers will be required to make an offer to holders of the Notes to repurchase their Notes at a price of 101% of their principal amount plus accrued and unpaid interest, if any, to, but not including, the repurchase date.
The obligations under the Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by the Company and all of CareTrust’s existing and future subsidiaries (other than the Issuers) that guarantee obligations under the Amended Credit Facility (as defined below); provided, however, that such guarantees are subject to automatic release under certain customary circumstances.
The indenture governing the Notes contains customary covenants such as limiting the ability of the Company and its restricted subsidiaries to: incur or guarantee additional indebtedness; incur or guarantee secured indebtedness; pay dividends or distributions on, or redeem or repurchase, capital stock; make certain investments or other restricted payments; sell assets; enter into transactions with affiliates; merge or consolidate or sell all or substantially all of their assets; and create restrictions on the ability of the Issuers and their restricted subsidiaries to pay dividends or other amounts to the Issuers. The indenture governing the Notes also requires the Company and its restricted subsidiaries to maintain a specified ratio of unencumbered assets to unsecured indebtedness. These covenants are subject to a number of important and significant limitations, qualifications and exceptions. The indenture governing the Notes also contains customary events of default.
As of September 30, 2021, the Company was in compliance with all applicable financial covenants under the indenture governing the Notes.

Unsecured Revolving Credit Facility and Term Loan
On February 8, 2019, the Operating Partnership, as the borrower, the Company, as guarantor, CareTrust GP, LLC, and certain of the Operating Partnership’s wholly owned subsidiaries entered into an amended and restated credit and guaranty agreement with KeyBank National Association, as administrative agent, an issuing bank and swingline lender, and the lenders party thereto (the “Amended Credit Agreement”). The Amended Credit Agreement provides for: (i) an unsecured revolving credit facility (the “Revolving Facility”) with revolving commitments in an aggregate principal amount of $600.0 million, including a letter of credit subfacility for 10% of the then available revolving commitments and a swingline loan subfacility for 10% of the then available revolving commitments and (ii) an unsecured term loan credit facility (the “Term Loan” and, together with the Revolving Facility, the “Amended Credit Facility”) in an aggregate principal amount of $200.0 million. Borrowing availability under the Revolving Facility is subject to no default or event of default under the Amended Credit Agreement having occurred at the time of borrowing. The proceeds of the Term Loan were used, in part, to repay in full all outstanding borrowings under the Company’s prior term loan and revolving facility under its prior credit agreement. Future borrowings under the Amended Credit Facility will be used for working capital purposes, for capital expenditures, to fund acquisitions and for general corporate purposes.
13

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


The interest rates applicable to loans under the Revolving Facility are, at the Operating Partnership’s option, equal to either a base rate plus a margin ranging from 0.10% to 0.55% per annum or LIBOR plus a margin ranging from 1.10% to 1.55% per annum based on the debt to asset value ratio of the Company and its consolidated subsidiaries (subject to decrease at the Operating Partnership’s election if the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt). The interest rates applicable to loans under the Term Loan are, at the Operating Partnership’s option, equal to either a base rate plus a margin ranging from 0.50% to 1.20% per annum or LIBOR plus a margin ranging from 1.50% to 2.20% per annum based on the debt to asset value ratio of the Company and its consolidated subsidiaries (subject to decrease at the Operating Partnership’s election if the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt). In addition, the Operating Partnership will pay a facility fee on the revolving commitments under the Revolving Facility ranging from 0.15% to 0.35% per annum, based on the debt to asset value ratio of the Company and its consolidated subsidiaries (unless the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt and the Operating Partnership elects to decrease the applicable margin as described above, in which case the Operating Partnership will pay a facility fee on the revolving commitments ranging from 0.125% to 0.30% per annum based on the credit ratings of the Company’s senior long-term unsecured debt). As of September 30, 2021, the Operating Partnership had $200.0 million outstanding under the Term Loan and $80.0 million of borrowings outstanding under the Revolving Facility.
The Revolving Facility has a maturity date of February 8, 2023, and includes, at the sole discretion of the Operating Partnership, two, six-month extension options. The Term Loan has a maturity date of February 8, 2026.
The Amended Credit Facility is guaranteed, jointly and severally, by the Company and its wholly owned subsidiaries that are party to the Amended Credit Agreement (other than the Operating Partnership). The Amended Credit Agreement contains customary covenants that, among other things, restrict, subject to certain exceptions, the ability of the Company and its subsidiaries to grant liens on their assets, incur indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations, amend organizational documents and pay certain dividends and other restricted payments. The Amended Credit Agreement requires the Company to comply with financial maintenance covenants to be tested quarterly, consisting of a maximum debt to asset value ratio, a minimum fixed charge coverage ratio, a minimum tangible net worth, a maximum cash distributions to operating income ratio, a maximum secured debt to asset value ratio, a maximum secured recourse debt to asset value ratio, a maximum unsecured debt to unencumbered properties asset value ratio, a minimum unsecured interest coverage ratio and a minimum rent coverage ratio. The Amended Credit Agreement also contains certain customary events of default, including the failure to make timely payments under the Amended Credit Facility or other material indebtedness, the failure to satisfy certain covenants (including the financial maintenance covenants), the occurrence of change of control and specified events of bankruptcy and insolvency.
As of September 30, 2021, the Company was in compliance with all applicable financial covenants under the Amended Credit Agreement.

7. EQUITY
Common Stock
At-The-Market Offering—On March 10, 2020, the Company entered into a new equity distribution agreement to issue and sell, from time to time, up to $500.0 million in aggregate offering price of its common stock through an “at-the-market” equity offering program (the “ATM Program”). In connection with the entry into the equity distribution agreement and the commencement of the ATM Program, the Company’s “at-the-market” equity offering program pursuant to the Company’s prior equity distribution agreement, dated as of March 4, 2019, was terminated (the “Prior ATM Program”).
14

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


There was no ATM Program activity for the three months ended September 30, 2021 and there was no Prior ATM Program or ATM Program activity for the three and nine months ended September 30, 2020. The following table summarizes the ATM Program activity for the nine months ended September 30, 2021 (in thousands, except per share amounts).
For the Nine Months Ended
September 30, 2021
Number of shares990 
Average sales price per share$23.74 
Gross proceeds(1)
$23,505 
(1) Total gross proceeds is before $0.3 million of commissions paid to the sales agents during the nine months ended September 30, 2021 under the ATM Program.
As of September 30, 2021, the Company had $476.5 million available for future issuances under the ATM Program.
Share Repurchase Program—On March 20, 2020, the Company’s Board of Directors authorized a share repurchase program to repurchase up to $150.0 million of outstanding shares of the Company’s common stock (the “Repurchase Program”). Repurchases under the Repurchase Program, which expires on March 31, 2023, may be made through open market purchases, privately negotiated transactions, structured or derivative transactions, including accelerated share repurchase transactions, or other methods of acquiring shares, in each case subject to market conditions and at such times as shall be permitted by applicable securities laws and determined by management. Repurchases under the Repurchase Program may also be made pursuant to a plan adopted under Rule 10b5-1 promulgated under the Exchange Act. The Company expects to finance any share repurchases under the Repurchase Program using available cash and may also use short-term borrowings under the Revolving Facility. The Company did not repurchase any shares of common stock under the Repurchase Program during the three and nine months ended September 30, 2021 and 2020. The Repurchase Program may be modified, discontinued or suspended at any time.
Dividends on Common StockThe following table summarizes the cash dividends on the Company’s common stock declared by the Company’s Board of Directors for the first nine months of 2021 (dollars in thousands, except per share amounts):
For the Three Months Ended
March 31, 2021June 30, 2021September 30, 2021
Dividends declared per share$0.265 $0.265 $0.265 
Dividends payment dateApril 15, 2021July 15, 2021October 15, 2021
Dividends payable as of record date$25,633 $25,714 $25,714 
Dividends record dateMarch 31, 2021June 30, 2021September 30, 2021

8. STOCK-BASED COMPENSATION
All stock-based awards are subject to the terms of the CareTrust REIT, Inc. and CTR Partnership, L.P. Incentive Award Plan (the “Plan”). The Plan provides for the granting of stock-based compensation, including stock options, restricted stock, performance awards, restricted stock units and other incentive awards to officers, employees and directors in connection with their employment with or services provided to the Company.
Restricted Stock Awards—In connection with the separation of the healthcare business and real estate business of Ensign into two separate and independent publicly traded companies (the “Spin-Off”) on June 1, 2014, employees of Ensign who had unvested shares of restricted stock were given one share of CareTrust REIT unvested restricted stock totaling 207,580 shares at the Spin-Off. These restricted shares were subject to a time vesting provision only and the Company did not recognize any stock compensation expense associated with these awards. During the year ended December 31, 2020, 1,760 shares were forfeited. At September 30, 2021, there were no unvested restricted stock awards outstanding.
In January 2021 and February 2021, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted 140,514 and 99,189 shares of restricted stock, respectively, to officers and employees. Each share had a fair market value on the date of grant of $22.48 and $22.18 per share, respectively, based on the closing market price of the Company’s common stock on that date, and the shares vest in three equal annual installments beginning on the first anniversary of the grant date.
15

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


In January 2021, the Compensation Committee granted 108,414 performance stock awards to officers. Each share had a fair market value on the date of grant of $22.48 per share, based on the closing market price of the Company’s common stock on that date. Performance stock awards are subject to both time and performance based conditions and vest over a one-to three-year period. The amount of such performance awards that will ultimately vest is dependent on the Company’s Normalized Funds from Operations per share, as defined by the Compensation Committee, meeting or exceeding a specified per share amount for the applicable vesting period.
Additionally, in February 2021, the Compensation Committee granted 99,189 performance stock awards to officers. Each share had an estimated fair market value on the date of grant of $27.98 per share. Performance stock awards are subject to both time and performance based conditions and cliff vest after a three-year period. The amount of such performance awards that will ultimately vest is dependent on the Company’s total shareholder return (“TSR”) performance relative to a custom TSR peer group consisting of 16 other publicly traded healthcare REITs on the date of grant and will range from 0% to 200% of the TSR awards initially granted. Compensation expense for awards with performance-based vesting conditions is recognized based upon the grant date fair value per share multiplied by the estimated number of performance stock awards to be earned after considering the Company’s expectation of future performance and is recognized provided that the requisite service is rendered, regardless of when, if ever, the market condition is satisfied. Forfeitures of stock-based awards are recognized as they occur.
The fair value of the TSR-based performance stock awards is estimated on the date of the grant using a Monte Carlo valuation model. The risk-free rate is based on the U.S. Treasury yield curve in effect at the grant date for the expected performance period. Expected volatility is based on historical volatility for the most recent 2.84 year period ending on the grant date for the Company and the selected TSR peer group, and is calculated on a daily basis. The following are the key assumptions used in this valuation:
Risk-free interest rate0.27 %
Expected stock price volatility52.93 %
Expected service period2.84 years
Expected dividend yield (assuming full reinvestment) %
In April 2021, the Compensation Committee granted 20,266 shares of restricted stock to non-employee members of the Board of Directors. Each share had a fair market value on the date of grant of $24.18 per share, based on the closing market price of the Company’s common stock on that date, and the shares vest in full on the earlier to occur of April 30, 2022 or the Company’s 2022 Annual Meeting of Stockholders.
The following table summarizes the stock-based compensation expense recognized during the periods presented (dollars in thousands):
 For the Three Months Ended September 30,For the Nine Months Ended September 30,
 2021202020212020
Stock-based compensation expense$1,802 $972 $5,197 $2,819 
As of September 30, 2021, there was $11.3 million of unamortized stock-based compensation expense related to unvested awards and the weighted-average remaining vesting period of such awards was 2.1 years. 
16

Table of Contents
CARETRUST REIT, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS —
(Unaudited)


9. EARNINGS PER COMMON SHARE
The following table presents the calculation of basic and diluted earnings per common share (“EPS”) for the Company’s common stock for the three and nine months ended September 30, 2021 and 2020, and reconciles the weighted-average common shares outstanding used in the calculation of basic EPS to the weighted-average common shares outstanding used in the calculation of diluted EPS (amounts in thousands, except per share amounts):
 
 For the Three Months Ended September 30,For the Nine Months Ended September 30,
 2021202020212020
Numerator:
Net income$11,918 $21,552 $53,721 $59,812 
Less: Net income allocated to participating securities(116)(75)(350)(224)
Numerator for basic and diluted earnings available to common stockholders$11,802 $21,477 $53,371 $59,588 
Denominator:
Weighted-average basic common shares outstanding96,297 95,214 95,922 95,195 
Dilutive market condition stock awards  15  
Weighted-average diluted common shares outstanding96,297 95,214 95,937 95,195 
Earnings per common share, basic$0.12 $0.23 $0.56 $0.63 
Earnings per common share, diluted$0.12 $0.23 $0.56 $0.63 
Antidilutive unvested restricted stock awards and performance awards excluded from the computation535 300